Skye Bioscience
SKYE
#10904
Rank
NZ$12.57 M
Marketcap
NZ$2.84
Share price
-5.35%
Change (1 day)
-50.36%
Change (1 year)

Market capitalization of Skye Bioscience (SKYE)

Market cap: NZ$12.57 Million

As of September 2026 Skye Bioscience has a market cap of NZ$12.57 Million. This makes Skye Bioscience the world's 10904th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Skye Bioscience from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$12.57 M-71.6%
2025NZ$44.28 M-66.54%
2024NZ$0.13 B149.35%
2023NZ$53.07 M128.01%
2022NZ$23.27 M-35.79%
2021NZ$36.24 M126.96%
2020NZ$15.96 M-54.94%
2019NZ$35.43 M-55.62%
2018NZ$79.85 M1104.7%
2017NZ$6.62 M-26.9%
2016NZ$9.06 M-55.46%
2015NZ$20.35 M-87.14%
2014NZ$0.15 B

End of Day market cap according to different sources

On Aug 31st, 2026 the market cap of Skye Bioscience was reported to be:

NZ$12.57 Million
by Nasdaq info icon info icon
NZ$12.57 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.27 B 18,001.08%๐Ÿ‡บ๐Ÿ‡ธ USA